Keyphrases
Clinical Analysis
100%
Randomized Clinical Trial
90%
Systematic Meta-analysis
81%
Borderline Personality Disorder
69%
Mentalization-based Treatment
65%
Major Depressive Disorder
52%
Meta-analysis
46%
Serious Adverse Events
45%
Placebo
40%
Beneficial Effects
38%
Active Placebo
35%
Harmful Effects
33%
COVID-19
32%
Living Systematic Review
32%
Mentalizing
23%
Adverse Events
23%
Quality of Life
22%
Network Meta-analysis
21%
Subthreshold
20%
Certainty of Evidence
20%
Confidence Interval
15%
Long-term Psychotherapy
15%
Psychotherapy
15%
Non-serious
14%
Venlafaxine
14%
Mirtazapine
14%
Duloxetine
14%
Individual Patient Data
13%
Tricyclic Antidepressants
13%
Personality Functioning
13%
Prospero
12%
Risk of Bias
12%
Depressive Symptoms
12%
Risk Ratio
12%
Personality Disorders
10%
Cochrane
10%
Review Authors
10%
Level of Functioning
10%
Clinical Significance
9%
Psychiatric Disorders
9%
All-cause Mortality
9%
Therapist
9%
Suicide Attempt
8%
Antidepressants
8%
Eight-step
8%
Suicide
8%
Risk of Bias Assessment
8%
Random Error
8%
ICD-11
8%
Intervention Effect
7%
Medicine and Dentistry
Sequential Analysis
60%
Randomized Clinical Trial
59%
Systematic Review
49%
Systematic Review with Meta-Analysis
46%
Placebo
39%
Major Depressive Episode
39%
Adverse Event
29%
Meta-Analysis
27%
Quality of Life
19%
Duloxetine
14%
Network Meta-Analysis
13%
COVID-19
13%
Patient-Data
13%
Outpatient
13%
Tricyclic Antidepressant
13%
Psychiatry
13%
Depression
10%
Mental Disorder
8%
Attention Deficit Disorder
7%
Antidepressant
7%
Borderline Personality Disorder
7%
Venlafaxine
7%
Mirtazapine
7%
Clinical Significance
7%
Neurologic Disease
6%
Electrical Brain Stimulation
6%
Adult Psychiatric Disorder
6%
Offspring
6%
Neurostimulation
6%
Trigeminal Nerve
6%
Clinical Trial
6%
Number Needed to Harm
5%
Mental Health
5%
Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
73%
Adverse Event
65%
Major Depression
39%
Borderline State
38%
Placebo
34%
Disease
29%
Symptom
16%
Venlafaxine
14%
Mirtazapine
14%
Personality Disorder
13%
Coronavirinae
13%
Clinical Trial
12%
Depression
11%
All Cause Mortality
11%
Functional Disease
9%
Antidepressant
7%
Injury
7%
Diseases
7%
Duloxetine
7%
Randomized Controlled Trial
6%
Molnupiravir
6%
Vaccine
6%
ICD-11
6%
Tricyclic Antidepressant
6%
Human Insulin
6%
Recombinant Human Insulin
6%
Insulin Dependent Diabetes Mellitus
6%
Short Acting Insulin
6%
Insulin Analog
6%
Number Needed to Harm
5%
Automutilation
5%
Viral Vector
5%
Clinical Research
5%
